Identification of <i>Trypanosoma cruzi </i>Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs

Identification of <i>Trypanosoma cruzi </i>Growth Inhibitors with Activity In Vivo within a Collection of Licensed Drugs

Chagas disease, caused by the parasite <i>Trypanosoma cruzi (T. cruzi)</i>, affects more than six million people worldwide, with its greatest burden in Latin America. Available treatments present frequent toxicity and variable efficacy at the chronic phase of the infection, when the dise...

Full description

Bibliographic Details
Main Authors: Nieves Martinez-Peinado, Nuria Cortes-Serra, Julian Sherman, Ana Rodriguez, Juan M. Bustamante, Joaquim Gascon, Maria-Jesus Pinazo, Julio Alonso-Padilla
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Microorganisms
Subjects:
Chagas disease
Trypanosoma cruzi
drugs
repositioning
phenotypic assays
Online Access:https://www.mdpi.com/2076-2607/9/2/406

Internet

https://www.mdpi.com/2076-2607/9/2/406

Similar Items